Mergers and Acquisitions

Date: 2016-07-14

Type of information: Company acquisition

Acquired company: Pro Farma (Switzerland)

Acquiring company: Recordati (Italy)

Amount: CHF 16 million

Terms:

• • On July 14, 2016, Recordati announced the acquisition of 100% of the share capital of Pro Farma AG, a Swiss pharmaceutical company with headquarters in Zug. The value of the transaction (enterprise value) is of CHF 16 million and will be funded from existing liquidity. The signing and closing of the transaction took place at the same time.

Details: Pro Farma, with expected 2016 revenues of around CHF 10 million, markets proprietary and in-licensed specialties in selected therapeutic areas which include both prescription and OTC drugs. The main brands are Lacdigest (tilactase), Tretinac (isotretinoin) and Urocit (potassium citrate). Furthermore, the company offers distribution and promotion services to other pharmaceutical companies.

Related:

Is general: Yes